Analysis and Commentary STEVEN GROSSMAN 6/19/20 Analysis and Commentary STEVEN GROSSMAN 6/19/20 How Well Is This Year's Appropriation Process Working? Read More Analysis and Commentary STEVEN GROSSMAN 6/12/20 Analysis and Commentary STEVEN GROSSMAN 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More Advocacy at a Glance STEVEN GROSSMAN 6/12/20 Advocacy at a Glance STEVEN GROSSMAN 6/12/20 House and Senate Set Schedule for FY 21 Appropriations Mark-Ups Read More Analysis and Commentary STEVEN GROSSMAN 6/5/20 Analysis and Commentary STEVEN GROSSMAN 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Commissioner Hahn’s Address to the Alliance Gains Wide Attention Read More Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Hurry Up and Slow Down (Once Again) Read More Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Procedural Path Cleared for House Mark-up Appropriations; Impediments Remain Read More Analysis and Commentary STEVEN GROSSMAN 5/15/20 Analysis and Commentary STEVEN GROSSMAN 5/15/20 How H.R. 6800 Might Impact the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Virtual Mark-ups: Prerequisite for Movement of Appropriations Bills Read More Analysis and Commentary STEVEN GROSSMAN 5/8/20 Analysis and Commentary STEVEN GROSSMAN 5/8/20 The Frieden Health Defense Funding Proposition Read More Advocacy at a Glance STEVEN GROSSMAN 5/8/20 Advocacy at a Glance STEVEN GROSSMAN 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More Analysis and Commentary STEVEN GROSSMAN 5/1/20 Analysis and Commentary STEVEN GROSSMAN 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent Read More Analysis and Commentary STEVEN GROSSMAN 4/24/20 Analysis and Commentary STEVEN GROSSMAN 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More Advocacy at a Glance STEVEN GROSSMAN 4/24/20 Advocacy at a Glance STEVEN GROSSMAN 4/24/20 Appropriations Committees Still Have No Schedule; House Rules Do Not Permit Remote Mark-ups Read More Analysis and Commentary STEVEN GROSSMAN 4/17/20 Analysis and Commentary STEVEN GROSSMAN 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More Analysis and Commentary STEVEN GROSSMAN 4/3/20 Analysis and Commentary STEVEN GROSSMAN 4/3/20 Advocating for a Responsibility-based "Ask" Read More Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA Read More Analysis and Commentary STEVEN GROSSMAN 3/27/20 Analysis and Commentary STEVEN GROSSMAN 3/27/20 Coronavirus, Pandemic Preparedness, and Beyond Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 6/19/20 Analysis and Commentary STEVEN GROSSMAN 6/19/20 How Well Is This Year's Appropriation Process Working? Read More
Analysis and Commentary STEVEN GROSSMAN 6/12/20 Analysis and Commentary STEVEN GROSSMAN 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More
Advocacy at a Glance STEVEN GROSSMAN 6/12/20 Advocacy at a Glance STEVEN GROSSMAN 6/12/20 House and Senate Set Schedule for FY 21 Appropriations Mark-Ups Read More
Analysis and Commentary STEVEN GROSSMAN 6/5/20 Analysis and Commentary STEVEN GROSSMAN 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More
Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Commissioner Hahn’s Address to the Alliance Gains Wide Attention Read More
Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Hurry Up and Slow Down (Once Again) Read More
Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Procedural Path Cleared for House Mark-up Appropriations; Impediments Remain Read More
Analysis and Commentary STEVEN GROSSMAN 5/15/20 Analysis and Commentary STEVEN GROSSMAN 5/15/20 How H.R. 6800 Might Impact the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Virtual Mark-ups: Prerequisite for Movement of Appropriations Bills Read More
Analysis and Commentary STEVEN GROSSMAN 5/8/20 Analysis and Commentary STEVEN GROSSMAN 5/8/20 The Frieden Health Defense Funding Proposition Read More
Advocacy at a Glance STEVEN GROSSMAN 5/8/20 Advocacy at a Glance STEVEN GROSSMAN 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More
Analysis and Commentary STEVEN GROSSMAN 5/1/20 Analysis and Commentary STEVEN GROSSMAN 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More
Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent Read More
Analysis and Commentary STEVEN GROSSMAN 4/24/20 Analysis and Commentary STEVEN GROSSMAN 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More
Advocacy at a Glance STEVEN GROSSMAN 4/24/20 Advocacy at a Glance STEVEN GROSSMAN 4/24/20 Appropriations Committees Still Have No Schedule; House Rules Do Not Permit Remote Mark-ups Read More
Analysis and Commentary STEVEN GROSSMAN 4/17/20 Analysis and Commentary STEVEN GROSSMAN 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More
Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More
Analysis and Commentary STEVEN GROSSMAN 4/3/20 Analysis and Commentary STEVEN GROSSMAN 4/3/20 Advocating for a Responsibility-based "Ask" Read More
Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA Read More
Analysis and Commentary STEVEN GROSSMAN 3/27/20 Analysis and Commentary STEVEN GROSSMAN 3/27/20 Coronavirus, Pandemic Preparedness, and Beyond Read More
